Transaction · 0001601830-26-000012

Hallett David

Hallett David, CSO, reported a transaction classified as withholding at RECURSION PHARMACEUTICALS, INC. involving 11400.000000 shares for an estimated $45372.00. Reported holdings after the transaction were 1109059.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

withholdingSEC transaction code FCSO
RXRXRECURSION PHARMACEUTICALS, INC.
Filing timeFeb 10
Trade dateFeb 06, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$3.85
Pre-filing
1mo ago +26.2%1w ago +8.8%1d ago -7.5%
Returns since
7d -10.1%30d -14.5%90d -15.3%180d -16.4%1y -8.8%

RXRX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
RXRX since 2026-02-10Filed 206 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
withholding
Code F
Identifier
0001601830-26-000012
Class A Common Stock
Transaction date
Feb 06, 2026
Filed Feb 10, 2026, 11:18 PM · 4d delay
Shares
11.4k sh
$398 per share
Estimated value
-$4.53M
Computed from shares × price
Holdings after
1.10M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Scientific Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2026 and every three months thereafter.

  2. F2

    This RSU vested immediately upon the grant date.

  3. F3

    Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.

Original filing · 0001601830-26-000012
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

RXRX